Back to Search
Start Over
Harnessing the therapeutic potential of host antiviral restriction factors that target HIV.
- Source :
-
Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2013 Jan; Vol. 11 (1), pp. 1-4. - Publication Year :
- 2013
- Subjects :
- APOBEC-3G Deaminase
Animals
Antigens, CD administration & dosage
Antiviral Restriction Factors
Carrier Proteins administration & dosage
Cytidine Deaminase administration & dosage
Cytidine Deaminase antagonists & inhibitors
GPI-Linked Proteins administration & dosage
GPI-Linked Proteins physiology
Gene Products, vif metabolism
Gene Products, vif physiology
Gene Targeting methods
HIV Infections genetics
HIV Infections virology
HIV-1 immunology
Host-Pathogen Interactions genetics
Host-Pathogen Interactions immunology
Humans
Mutagenesis
Tripartite Motif Proteins
Ubiquitin-Protein Ligases
Virus Replication genetics
Virus Replication immunology
Anti-HIV Agents therapeutic use
Antigens, CD physiology
Carrier Proteins physiology
Cytidine Deaminase physiology
HIV Infections therapy
HIV-1 genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1744-8336
- Volume :
- 11
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Expert review of anti-infective therapy
- Publication Type :
- Editorial & Opinion
- Accession number :
- 23428096
- Full Text :
- https://doi.org/10.1586/eri.12.146